CD274 and cancer: Cancer immunotherapy with the immune checkpoint blockade agents, such as PD-1/PD-L1 antibodies, has been widely used in the clinic against certain kinds of cancers.6 However, the effectiveness of these drugs in other cancers is still unsatisfactory.